Who ensures compounding pharmacy quality and how

Compounding pharmacy quality is governed by several overlapping layers. No single body handles everything. Understanding who does what helps patients and prescribers evaluate the pharmacies they work with.

Who regulates compounding pharmacies

State boards of pharmacy (in plain English: the state-level agencies that license and oversee pharmacies) are the primary regulators for 503A compounding pharmacies — the category that fills individual patient prescriptions. Each state sets its own licensing requirements, inspection schedules, and enforcement authority.

The FDA also has oversight authority for compounding pharmacies, particularly when products cross state lines or raise public health concerns. Under the Drug Quality and Security Act of 2013, the FDA can inspect 503A pharmacies and issue warning letters for violations. A 2023 FDA report documented inspections across hundreds of compounding facilities, citing sterility and labeling failures as the most common findings.

The National Association of Boards of Pharmacy (NABP) supports interstate coordination and maintains the Not Recommended list of online pharmacies that fail pharmacy practice standards.

How is compounding pharmacy quality verified

Several mechanisms exist, though not all pharmacies use all of them. State board inspections are the baseline — frequency varies by state. Beyond inspections, quality is verified through:

• Testing: Pharmacies may conduct potency, sterility, and endotoxin testing on finished preparations, either in-house or through third-party labs.
• Standard compliance: Adherence to USP 797 (for sterile preparations) sets procedures for cleanroom conditions, personnel training, and beyond-use dating.
• Voluntary accreditation: The Pharmacy Compounding Accreditation Board (PCAB), operated through NABP, conducts independent site audits against published standards.

Learn more about sterility testing for compounded peptides and what happens inside a compounding pharmacy.

What is USP 797 compliance

USP 797 — a chapter within the United States Pharmacopeia (the official compendium of drug quality standards) — sets enforceable requirements for sterile compounding environments. It covers cleanroom classification, personnel training and garbing, environmental monitoring, beyond-use dating, and sterility testing protocols.

The United States Pharmacopeia publishes USP 797 and updates it periodically. The most recent revision took effect in November 2023. State boards of pharmacy determine whether and how to adopt USP 797 into their regulations — most have.

Compounding pharmacies that meet USP 797 requirements and pursue PCAB accreditation have undergone more external scrutiny than pharmacies with state licensure alone. Neither verifications a perfect product, but they represent meaningful quality signals.

For more context on the regulatory environment, see how FDA reclassification affects compounded peptides and what off-label prescribing means. The sterile filtration process is a key step in producing injectable preparations.

Frequently asked questions

Who regulates compounding pharmacies? State boards of pharmacy are the primary regulators for 503A compounding pharmacies. The FDA holds additional authority, especially when products cross state lines or public health issues arise.

How is compounding pharmacy quality verified? Through state board inspections, third-party sterility and potency testing, USP 797 compliance, and optional PCAB accreditation. The level of scrutiny varies by pharmacy.

What is USP 797 compliance? USP 797 is a United States Pharmacopeia chapter that sets mandatory standards for sterile compounding environments — covering cleanrooms, personnel training, environmental monitoring, and sterility testing. Most states have adopted it into their pharmacy regulations.

What is PCAB accreditation? PCAB — the Pharmacy Compounding Accreditation Board — is a voluntary accreditation program operated through NABP. Accredited pharmacies undergo independent on-site audits against published compounding quality standards.

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.